Your session is about to expire
← Back to Search
Other
NeurOS Monitoring for Carotid Disease Surgery (COBBV-CE Trial)
N/A
Waitlist Available
Led By Jiapeng Huang, MD, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the beginning of surgery until the end of surgery for each patient enrolled
Awards & highlights
COBBV-CE Trial Summary
This trial looked at how well a new system, NeurOS, could measure changes in oxygen and blood levels in the brain during surgery to remove blockages in the carotid artery.
Who is the study for?
This trial is for individuals undergoing carotid endarterectomy at Jewish Hospital in Louisville, KY. Participants must agree to the study protocol and not have allergies to INOVS or NeurOS system pads. It's not open to those who refuse participation, have relevant allergies, or require emergency surgery.Check my eligibility
What is being tested?
The trial is studying how a device called NeurOS affects brain oxygen levels and blood volume during carotid artery surgery. The goal is to understand if this monitoring can improve patient outcomes.See study design
What are the potential side effects?
Since the NeurOS system is used for monitoring during surgery rather than treatment, it may cause minimal side effects related to pad placement on the skin such as discomfort or potential skin irritation.
COBBV-CE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the beginning of surgery until the end of surgery for each patient enrolled
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the beginning of surgery until the end of surgery for each patient enrolled
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Regional Cerebral Oxygenation
Secondary outcome measures
NeurOS Brain Blood Volume
COBBV-CE Trial Design
1Treatment groups
Experimental Treatment
Group I: NeurOS GroupExperimental Treatment1 Intervention
Apply the single use NeurOS cerebral oximetry sensor adhesive onto patients' head who are going to have CEA surgery in the operating room before anesthesia induction.
Find a Location
Who is running the clinical trial?
University of LouisvilleLead Sponsor
338 Previous Clinical Trials
75,984 Total Patients Enrolled
Jiapeng Huang, MD, PhDPrincipal Investigator - University of Louisville
University of Louisville
4 Previous Clinical Trials
407 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not want to be part of the study.You are allergic to the pads used in the INOVS or NeurOS system.You need to have surgery immediately.You are not allergic to the pads used for the INOVS or NeurOS systems.
Research Study Groups:
This trial has the following groups:- Group 1: NeurOS Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still room for volunteers to join this research endeavor?
"Confirming the information on clinicaltrials.gov, this investigation is still open to participants; it was initially posted on January 1st 2023 and its details were last updated in May 7th 2022."
Answered by AI
What is the capacity of participants for this experimental process?
"Affirmative. Clinicaltrials.gov documents verify that this research is recruiting, having been posted on January 1st 2023 and updated lastly on May 7th 2022. The medical trial requires 100 participants from a single location to take part."
Answered by AI
Share this study with friends
Copy Link
Messenger